Insider Trading disclosures for Voyager Therapeutics Inc

The latest disclosure was made by Nathan Jorgensen in Voyager Therapeutics Inc where a trade of 103,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Nathan Jorgensen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	103,000	103,000	-		-	Stock Option (Right to Buy)
Nathan Jorgensen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	51,500	131,500 (0%)	0%		0	Common Stock
Sandell Jacquelyn Fahey	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	41,500	123,143 (0%)	0%		0	Common Stock
Sandell Jacquelyn Fahey	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	83,000	83,000	-		-	Stock Option (Right to Buy)
Toby Ferguson	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	63,000	168,000 (0%)	0%		0	Common Stock
Toby Ferguson	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	126,000	126,000	-		-	Stock Option (Right to Buy)
Alfred W. Sandrock	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	145,000	441,816 (1%)	0%		0	Common Stock
Alfred W. Sandrock	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	290,000	290,000	-		-	Stock Option (Right to Buy)
Alfred W. Sandrock	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 4.24 per share.	20 Feb 2025	11,702	296,816 (0%)	0%	4.2	49,616	Common Stock
Robin Swartz	COO & CBO	Sale of securities on an exchange or to another person at price $ 4.25 per share.	20 Feb 2025	3,894	98,397 (0%)	0%	4.3	16,550	Common Stock
Robin Swartz	COO & CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	71,250	169,647 (0%)	0%		0	Common Stock
Robin Swartz	COO & CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	142,500	142,500	-		-	Stock Option (Right to Buy)
Todd Carter	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 4.26 per share.	20 Feb 2025	3,305	77,718 (0%)	0%	4.3	14,079	Common Stock
Todd Carter	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	92,000	92,000	-		-	Stock Option (Right to Buy)
Todd Carter	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	46,000	123,718 (0%)	0%		0	Common Stock
Alfred W. Sandrock	President & CEO	Sale of securities on an exchange or to another person at price $ 4.45 per share.	11 Feb 2025	16,644	308,518 (0%)	0%	4.5	74,066	Common Stock
Robin Swartz	COO & CBO	Sale of securities on an exchange or to another person at price $ 4.45 per share.	11 Feb 2025	6,950	102,291 (0%)	0%	4.5	30,928	Common Stock
Todd Carter	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 4.45 per share.	11 Feb 2025	5,413	81,023 (0%)	0%	4.5	24,088	Common Stock
Sandell Jacquelyn Fahey	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 4.45 per share.	11 Feb 2025	4,358	81,643 (0%)	0%	4.4	19,393	Common Stock
Robin Swartz	COO & CBO	Sale of securities on an exchange or to another person at price $ 5.09 per share.	14 Jan 2025	3,087	109,241 (0%)	0%	5.1	15,713	Common Stock
Todd Carter	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 5.13 per share.	14 Jan 2025	1,191	86,436 (0%)	0%	5.1	6,110	Common Stock
Robin Swartz	COO&CBO	Sale of securities on an exchange or to another person at price $ 5.65 per share.	23 Dec 2024	6,500	112,328 (0%)	0%	5.7	36,725	Common Stock
Sandell Jacquelyn Fahey	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 5.82 per share.	02 Oct 2024	5,999	86,001 (0%)	0%	5.8	34,914	Common Stock
Nathan Jorgensen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2024	80,000	80,000 (0%)	0%		0	Common Stock
Nathan Jorgensen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	200,000	200,000	-		-	Stock Option (Right to Buy)
James A. Geraghty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
George A. Scangos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Glenn F. Pierce	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Catherine J. Mackey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Steven E. Hyman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Grace E. Colon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Nancy Vitale	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Jude Onyia	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Alfred W. Sandrock	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 9.86 per share.	02 Apr 2024	12,115	322,839 (0%)	0%	9.9	119,454	Common Stock
Robin Swartz	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 9.88 per share.	02 Apr 2024	1,357	117,004 (0%)	0%	9.9	13,407	Common Stock
Toby Ferguson	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	105,000	105,000 (0%)	0%		0	Common Stock
Toby Ferguson	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	210,000	210,000	-		-	Stock Option (Right to Buy)
W. Alfred Sandrock	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 7.46 per share.	21 Feb 2024	13,033	334,954 (0%)	0%	7.5	97,226	Common Stock
Peter Pfreundschuh P.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 7.46 per share.	21 Feb 2024	3,764	175,669 (0%)	0%	7.5	28,079	Common Stock
Robin Swartz	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 7.45 per share.	21 Feb 2024	3,966	118,361 (0%)	0%	7.5	29,547	Common Stock
Todd Carter	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 7.47 per share.	20 Feb 2024	3,365	87,627 (0%)	0%	7.5	25,137	Common Stock
Carter Todd	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	20 Feb 2024	602	90,992 (0%)	0%	7.7	4,623	Common Stock
Fahey Sandell Jacquelyn	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	62,000	62,000	-		-	Stock Option (Right to Buy)
Todd Carter	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	77,000	77,000	-		-	Stock Option (Right to Buy)
W. Sandrock Alfred	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	260,000	260,000	-		-	Stock Option (Right to Buy)
Alfred W. Sandrock	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	130,000	347,987 (0%)	0%		0	Common Stock
Carter Todd	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	38,500	91,594 (0%)	0%		0	Common Stock
Robin Swartz	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	100,000	100,000	-		-	Stock Option (Right to Buy)
P. Peter Pfreundschuh	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2024	60,000	60,000	-		-	Stock Option (Right to Buy)

Showing 1 to 50 of 283 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low in past week

Insider Trading disclosures for Voyager Therapeutics Inc

The latest disclosure was made by Nathan Jorgensen in Voyager Therapeutics Inc where a trade of 103,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 21, 2025.

Screeners based on Insider Trading and SAST parameters